Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. North America Enteral Nutrition Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of North America Enteral Nutrition Market 26
Figure 8. Primary Restraints and Impact Factors of North America Enteral Nutrition Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of North America Enteral Nutrition Market 36
Figure 11. Breakdown of North America Enteral Nutrition Market by Nutrient, 2019-2030, % of Revenue 41
Figure 12. North America Addressable Market Cap in 2020-2030 by Nutrient, Value ($ mn) and Share (%) 41
Figure 13. North America Enteral Nutrition Market: Protein Based Nutrition, 2019-2030, $ mn 42
Figure 14. North America Enteral Nutrition Market: Standard Protein Diet, 2019-2030, $ mn 44
Figure 15. North America Enteral Nutrition Market: High Protein Supplement, 2019-2030, $ mn 45
Figure 16. North America Enteral Nutrition Market: Protein for Diabetic Patients, 2019-2030, $ mn 46
Figure 17. North America Enteral Nutrition Market: Other Protein-based Nutitions, 2019-2030, $ mn 47
Figure 18. North America Enteral Nutrition Market: Carbohydrates Based Nutrition, 2019-2030, $ mn 48
Figure 19. North America Enteral Nutrition Market: Fat Based Nutrition, 2019-2030, $ mn 49
Figure 20. North America Enteral Nutrition Market: Vitamin Based Nutrition, 2019-2030, $ mn 50
Figure 21. North America Enteral Nutrition Market: Other Nutrition Types, 2019-2030, $ mn 51
Figure 22. Breakdown of North America Enteral Nutrition Market by Application, 2019-2030, % of Sales Revenue 53
Figure 23. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 53
Figure 24. North America Enteral Nutrition Market: Critical Care, 2019-2030, $ mn 54
Figure 25. North America Enteral Nutrition Market: Diabetes, 2019-2030, $ mn 55
Figure 26. North America Enteral Nutrition Market: Neurology, 2019-2030, $ mn 56
Figure 27. North America Enteral Nutrition Market: Oncology, 2019-2030, $ mn 57
Figure 28. North America Enteral Nutrition Market: Other Applications, 2019-2030, $ mn 58
Figure 29. Breakdown of North America Enteral Nutrition Market by Category, 2019-2030, % of Sales Revenue 61
Figure 30. North America Addressable Market Cap in 2020-2030 by Category, Value ($ mn) and Share (%) 61
Figure 31. North America Enteral Nutrition Market: Enteral Nutrition for Chronic Illness, 2019-2030, $ mn 62
Figure 32. North America Enteral Nutrition Market: Enteral Nutrition with Standard Formula, 2019-2030, $ mn 63
Figure 33. Breakdown of North America Enteral Nutrition Market by Product Form, 2019-2030, % of Revenue 65
Figure 34. North America Addressable Market Cap in 2020-2030 by Product Form, Value ($ mn) and Share (%) 65
Figure 35. North America Enteral Nutrition Market: Liquid Enteral Nutrition, 2019-2030, $ mn 66
Figure 36. North America Enteral Nutrition Market: Powder Enteral Nutrition, 2019-2030, $ mn 67
Figure 37. Breakdown of North America Enteral Nutrition Market by End User, 2019-2030, % of Revenue 69
Figure 38. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 69
Figure 39. North America Enteral Nutrition Market: Pediatric, 2019-2030, $ mn 70
Figure 40. North America Enteral Nutrition Market: Adults, 2019-2030, $ mn 71
Figure 41. North America Enteral Nutrition Market: Geriatric, 2019-2030, $ mn 72
Figure 42. Breakdown of North America Enteral Nutrition Market by Distribution Channel, 2019-2030, % of Revenue 73
Figure 43. North America Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 74
Figure 44. North America Enteral Nutrition Market: Distribution by Hospitals, 2019-2030, $ mn 75
Figure 45. North America Enteral Nutrition Market: Distribution by Retail Pharmacies, 2019-2030, $ mn 76
Figure 46. North America Enteral Nutrition Market: Distribution by Online Pharmacies, 2019-2030, $ mn 77
Figure 47. Breakdown of North America Enteral Nutrition Market by Country, 2019 and 2030, % of Revenue 79
Figure 48. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 80
Figure 49. U.S. Enteral Nutrition Market, 2019-2030, $ mn 82
Figure 50. Canada Enteral Nutrition Market, 2019-2030, $ mn 85
Figure 51. Enteral Nutrition Market in Mexico, 2015-2030, $ mn 87
Figure 52. Growth Stage of North America Enteral Nutrition Industry over the Forecast Period 89
North America enteral nutrition market is expected to grow by 7.3% annually in the forecast period and reach $5,873.8 million by 2030 driven by rising number of patients suffering with chronic diseases and surge in adoption of enteral nutrition amid COVID-19 pandemic. Highlighted with 27 tables and 52 figures, this 112-page report “North America Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country. Based on Nutrient, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Protein Based Nutrition • Standard Protein Diet • High Protein Supplement • Protein for Diabetic Patients • Other Protein-based Nutitions Carbohydrates Based Nutrition Fat Based Nutrition Vitamin Based Nutrition Other Nutrition Types Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Critical Care • Diabetes • Neurology • Oncology • Other Applications Based on Category, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Enteral Nutrition for Chronic Illness • Enteral Nutrition with Standard Formula Based on Product Form, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Liquid Enteral Nutrition • Powder Enteral Nutrition Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pediatric • Adults • Geriatric Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Distribution by Hospitals • Distribution by Retail Pharmacies • Distribution by Online Pharmacies Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in North America enteral nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories B. Braun Melsungen AG Baxter International, Inc. Danone S.A. Fresenius Kabi AG North America Health Products, Inc. Hormel Foods Corporation Mead Johnson Nutrition Company Meiji Holdings Co., Ltd. Nestle S.A. Reckitt Benckiser Group LLC Victus, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More